Advertisement

Topics

The Effect of DHEA on Markers of Ovarian Reserve in Women With Diminished Ovarian Reserve

2014-07-23 21:08:59 | BioPortfolio

Summary

This prospective study evaluates the effect of DHEA supplementation on markers of ovarian reserve in women with diminished ovarian reserve.

Description

Ovarian reserve markers, such as FSH, estradiol, AMH, ovarian volume and antral follicle counts will be monitored on DHEA supplementation in a prospective fashion.

Study Design

Allocation: Non-Randomized, Control: Uncontrolled, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Conditions

Women With Diminished Ovarian Reserve

Intervention

dehydroepiandrosterone

Location

Virginia Center for Reproductive Medicine
Reston
Virginia
United States
20190

Status

Recruiting

Source

Virginia Center for Reproductive Medicine

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-07-23T21:08:59-0400

Clinical Trials [1386 Associated Clinical Trials listed on BioPortfolio]

Thalidomide Results in Diminished Ovarian Reserve in Reproductive Age Female IBD Patients

The effectiveness of thalidomide in treating inflammatory bowel disease has been widely recognized. Meanwhile, many serious adverse drug reactions were notified, but no reports on ovaria...

The Use of DHEA in Women With Premature Ovarian Failure

DHEA supplementation has been used in women with infertility and diminished ovarian reserve. There is a small report in 5 women with POF that benefited from the use of DHEA over several mo...

Follicle Activation by Inhibition of the Hippo Pathway

The aim of this project is to activate recruitment and growth of resting primordial follicles in the ovaries of women with diminished ovarian reserve, in attempt to increase the chance to ...

Dehydroepiandrosterone (DHEA) Treatment and Premature Ovarian Failure (POF)

The experimental focus of this project is on the interaction of DHEA treatment on pregnancy in women with open tubes, fertile male partners and evidence of premature ovarian failure.

Ovarian Reserve in Patients With Psoriasis

Psoriasis is a common autoimmune disease. It affects women of all ages including reproductive years. Autoimmune diseases including psoriasis are linked to premature ovarian reserve. This s...

PubMed Articles [6912 Associated PubMed Articles listed on BioPortfolio]

MiR-106a increases granulosa cell viability and is down-regulated in women with diminished ovarian reserve.

Women with diminished ovarian reserve (DOR) suffer from reduced fertility, cardiovascular events and osteoporosis. Though differential microRNA (miRNA) expression has been described in several ovarian...

Association between ovarian endometrioma and ovarian reserve.

Endometrioma is one of the main pathologies of endometriosis, though its pathogenesis still remains enigmatic. Ovarian reserve is defined as the number and quality of the follicles left in the ovary a...

Dehydroepiandrosterone as a potential agent to slow down ovarian aging.

Ovarian aging, which leads to diminished ovarian reserve and decreased oocyte quality, is highly associated with poor reproductive outcomes. It has been suggested that dehydroepiandrosterone (DHEA) mi...

What women want? A scoping survey on women's knowledge, attitudes and behaviours towards ovarian reserve testing and egg freezing.

We aimed to investigate women's knowledge, attitudes and behaviours towards ovarian reserve testing and egg freezing for non-medical reasons in the general population.

25-Hydroxyvitamin D (25(OH)D) and biomarkers of ovarian reserve.

The aim of the study was to examine the associations between 25-hydroxyvitamin D (25(OH)D) and biomarkers of ovarian reserve in a large community-based sample of women.

Medical and Biotech [MESH] Definitions

Capacity of the ovary to provide viable eggs.

A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.

Men and women serving on active duty in the military, or in a reserve military force, and their immediate family including spouses, children, and parents.

The period before MENOPAUSE. In premenopausal women, the climacteric transition from full sexual maturity to cessation of ovarian cycle takes place between the age of late thirty and early fifty.

Cessation of ovarian function after MENARCHE but before the age of 40, without or with OVARIAN FOLLICLE depletion. It is characterized by the presence of OLIGOMENORRHEA or AMENORRHEA, elevated GONADOTROPINS, and low ESTRADIOL levels. It is a state of female HYPERGONADOTROPIC HYPOGONADISM. Etiologies include genetic defects, autoimmune processes, chemotherapy, radiation, and infections.

More From BioPortfolio on "The Effect of DHEA on Markers of Ovarian Reserve in Women With Diminished Ovarian Reserve"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...


Searches Linking to this Trial